Abstract
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.

This publication has 26 references indexed in Scilit: